Join our webinar to learn how CRO (contract research organization) Concept Life Sciences (CLS) and Malvern Panalytical can accelerate the progress of your antibody drug conjugates (ADCs) projects. We’ll be joined by Dr Jamie Stokes, a medicinal chemist and principal research scientist at CLS, who will present a case study from CLS’s labs to discuss current methods and challenges in the synthesis and characterization of novel ADCs.
In this webinar, we will cover:
- ADC synthesis
- Structural characterization by subunit analysis and peptide mapping
- The effect of antibodies and ADCs against target antigen-expressing and non-target antigen-expressing cell lines to study ADC specificity and their time dependent effect on apoptosis using an IncuCyte®
- How Malvern Panalytical’s analytical instrumentation can speed up ADC research and development
Speakers
Muneera Beech Ph.D. - Field Application Scientist - Malvern Panalytical
Jamie Stokes Ph.D. - Research Leader Concept Life Sciences
More information
- Who should attend?
- Anyone that has one of these job titles or anyone interested in ADC's: Senior Scientist, Principal Scientist, Lead Scientist, Head of Research and Development, VP Science, VP Chemistry, VP Biologics, Head of Business Development, Business Development Executive, Proposals Manager, VP of Business Development, Chief Scientific Officer, Head of Outsourcing, Project Manager, Product Manager, Head of API, Bioconjugation Scientist, Group Leader, Chief Executive Officer
- What will you learn?
- ADC synthesis
- Structural characterization by subunit analysis and peptide mapping
- The effect of antibodies and ADCs against target antigen-expressing and non-target antigen-expressing cell lines to study ADC specificity and their time dependent effect on apoptosis using an IncuCyte®
- How Malvern Panalytical’s analytical instrumentation can speed up ADC research and development